Skip Navigation

Cardio NewsWire - archive

Click here to return to the main Cardio NewsWire page.

The Cardio NewsWire site hosts highlighted news stories from the field of cardiology. This page holds an archive of previous stories published within the last 90 days, after this time stories are removed from the site.

Acute Cardiovascular Care 2014
Ethica Award 2014 to Adnan Kastrati
Periodontal disease a cardiovascular risk factor?
Microcirculation Meeting
Call for Abstracts
BCS Annual Conference 2014
ESC Webinars coming
EHRA Proctor programme
Heart Failure Association of ESC endorses White Paper
New EHJ Deputy Editor for Imaging
Renal Denervation Fails
Cardiology Update 2015


Acute Cardiovascular Care 18-20 October in Geneva, the meeting place for scientific exchange, fruitful discussions and endless opportunities to network and learn about the latest developments in your speciality.

This year's theme is The Highly Vulnerable Patient, and the Congress Committee has carefully constructed a programme that is rich in educational and state of the art content. Here are a few highlights from the scientific programme, not to be missed:
NEW! Sceptic's Corner
The vulnerable STEMI patient
Cooling after out of hospital cardiac arrest
Pre-hospital diagnosis and management of cardiac emergencies
NEW! First Aid for lay people, a joint session with the International Federation of Red Cross and Red Crescent Societies
Emergent situations in patients on new oral anticoagulants
• NEW! Hotline Session - Submission will soon be open for researchers wishing to present their latest clinical trials and research.


Each year the EuroPCR Board recognises an outstanding physician for their contribution to cardiovascular intervention as teacher, scientist, care provider or pioneer with the presentation of the Ethica Award.

The 2014 Ethica Award was presented to Adnan Kastrati at the EuroPCR Congress in Paris by William Wijns the EuroPCR chairman who commented, “His academic track record is amazing. The awardee belongs to the select group of cardiologists who have published over 500 original articles and numerous outstanding editorials. He is considered a top level trialist and reviewer by many reference journals and funding bodies”.

In his research, Kastrati has focussed on optimising treatment strategies in patients with acute coronary syndrome and developing new drug-coated stents with improved safety and efficacy profile. He has also explored the optimisation of adjunctive peri-procedural antithrombotic therapy and the evaluation of prognosis based on genetic and biochemical markers.

Adnan Kastrati is currently Professor of Cardiology and Head of the Catheterization Laboratory at Deutsches Herzzentrum, and Director of the ISAR Research Centre, Munich, Germany.

Accepting the award Kastrati said, “I see this award not only for me, but the whole ISAR team. It has been a great time to work with all these people”.

Periodontal disease associated with cardiovascular risk in large multicentre study

Should dental health now be considered a marker of coronary heart disease?

Periodontal disorders such as tooth loss and gingivitis have been identified as a potential risk marker for cardiovascular disease in a large study published by the European Journal of Preventive Cardiology (1).

More than 15,000 patients with chronic coronary heart disease provided information on their dental health, with results showing that indicators of periodontal disease (fewer remaining teeth, gum bleeding) were common in this patient group and associated with numerous cardiovascular and socioeconomic risk factors.

Conversely, a lower prevalence of tooth loss was associated with lower levels of CVD risk factors, including lower glucose levels, low-density lipoprotein cholesterol levels, systolic blood pressure, and waist circumference. Diabetes and smoking were also less prevalent among patients with more teeth, while the likelihood of higher education, alcohol consumption and work stress was greater.

The report, published in the European Journal of Preventive Cardiology, summarised information on self-reported dental health from the STABILITY trial, a clinical trial involving 15,828 participants from 39 countries all with chronic coronary heart disease and at least one additional risk factor for CHD. This, say the authors, is the largest study of its kind to assess dental disease in coronary patients, and demonstrates a heavier burden of CVD risk factors and higher levels of biomarkers among those with more tooth loss and gum bleeding, even after adjusting for confounders (such as age, smoking, diabetes and education level). The findings suggest common risk factors for dental disease and coronary heart disease, and raise the question of whether self-described dental health can now be considered a useful marker of CVD risk.

1. Vedin O, Hagström E, Gallup D, et al. Periodontal disease in patients with chronic coronary heart disease: Prevalence and association with cardiovascular risk factors. Eur J Prevent Cardiol 2014; DOI: 10.1177/2047487314530660


The third Joint Meeting of the German Society for Microcirculation and Vascular Biology (GfMVB) and the Swiss Society for Microcirculation and Vascular Research (SSMVR) will take place from 30 September – 2 October 2014 in Münster, Germany.

The program will include renowned experts in microcirculation speaking on the dynamics of the vasculature together with many oral and poster presentations by different investigators. An additional highlight will be different workshops concerning the imaging of live cells and a workshop on protein dynamics in endothelium.

The deadline for abstract submission is on 30 June, 2014

Furthermore there will be the Young Investigator Award Session.

The Hermann-Rein Prize 2014 will be awarded during the 3rd Joint Meeting. Please note the deadline of July 1, 2014 for the Hermann-Rein Prize submissions.

For more details please visit the following link:


The 21st International Postgraduate Course on Cardiovascular Disease.

Cardiology Update
An ESC Update Programme in Davos, Switzerland, 8-12 February 2015 is now inviting submission of abstracts.

Abstracts can be submitted online only and will be accepted for poster presentations. Deadline is noon CET, 21 December 2014.

Guidelines and instructions for submission are available at


The 2014 Conference will be the largest ever in plenary sessions (76), hot topics (over 120) and anticipated delegates. Over 3000 delegates are expected to attend.

Every year the organisers endeavour to improve the programme of educational activities and also introduce something ‘a little different’, to attract the delegates’ interest during the 3 days!

The Highlight theme of the 2014 Programme is: “Tomorrow’s World”.

The main programme is divided into dedicated tracks.

National Training Day - including SAC session

Education for Revalidation - based on the Cardiology Curriculum

• Imaging- multi-modality imaging and abstract poster session

Clinical Science Translational Research (CSTR) - including the Young Research Workers Prize (YRWP) and Michael Davies Early Career Award and abstract poster sessions

Basic Science - the BAS/BSCR Spring meeting with basic science abstract poster sessions presented in the Basic Science track

BCS - Provided by the Programme Committee- some old favourites (BCS Quiz, Top 10 Trials) here but also NEW sessions includingJBS3 and focussed sessions for revalidation (Lifelong Learning- dedicated interactive case based sessions- need to sign up for these) and some entertainment (‘Cardiology rocks’ is CPEX testing with a difference!). Also, meet the man who has climbed Everest 8 times!

Named lectures - from Dr Rick Nishimura and Prof Barbara Casadei

Affiliated Groups - with dedicated sessions, joint sessions and tracks

BHF Healthcare Professionals - NEW this year

Over 150 abstracts will be presented in the CSTR track andimaging track.

Education Hall: is a dedicated area for interactive education:

• Poster sessions

• Simulation- There will be 15 technical simulators available with supervised training by experienced consultants. For the first time there will be pericardiocentesis training.

• Imaging village- Interactive work stations for CT, MRI and echo will be available to all, with opportunity to undertake echo scans on volunteers. Supervised by trainers. Book in advance on-line

• MRI scanner- will be on site. Volunteers will undergo scans and delegates can get involved in post processing and interpretation. Book in advance on-line

Resuscitation skills - sign up to sessions to join a resuscitation team to improve your skills. Book in advance on-line

Hot topics - back by popular demand! Over 120 hot topics over 3 days with 3 BCS run subspecialty zones and 1 BHF zone (covering research)! See the newJBS3 risk calculator and App in action!

• Industry stands- look out for the education agenda provided by industry colleagues on their stands.

The Annual Dinner will be on Tuesday 3 June 2014


15 May: ESC Webinar on The Evolving Role of Cardiac Resynchronization Therapy in Heart Failure: from correct patient selection, to long term follow-up with Christophe Leclercq & Haran Burri

20 May: EACVI webinar on the Role of imaging in Heart Failure with Johan De Sutter & Erwan Donal

22 May: ACCA webinar on Cardiac Arrest with Nikolaos Nikolaou, Susanna Price and Bulent Gorenek

23 May: EHRA Webinar on Which patient is indicated for an ICD? with Frieder Braunschweig and Markus Zabel

26 May: Heart Failure webinar on Iron deficiency in heart failure - From evidence to practice with Stefan Anker and Piotr Ponikowski

10 June: ESC Webinar on Treating the patient with diabetes and cardiovascular disease: tips and tricks for the clinical cardiologist
with Lars Ryden and Peter Grant

17 June 2014: EACVI webinar on Pearls and pitfalls in deformation
with Thor Edvardsen & Peter Sogaard

24 June : EHRA Webinar on Managing the Risk of Sudden Cardiac Death using a Wearable Cardioverter Defibrillator
with Christian Perings and Lucas Boersma

EACVI also offers "On demand webinars" in many languages:

all previous EACVI webinars can be watched in your own time and in multi languages.

ESC Webinar on Heart Failure with Preserved Ejection Fraction: the most common diagnostic and therapeutic challenges

EACVI translated webinar recordings available for all

ACCA webinar on STEMI


The EHRA Proctor programme has been created to ease the transition from Fellowship to independent practice for former EHRA Fellows and to acquire additional techniques, either in the field of Arrhythmias or Cardiac Pacing.

Centres and individuals that wish to take part should submit their applications by 30 July 2014.


On 16 May, the Heart Failure Association of the ESC (HFA) endorsed the White Paper ‘Heart failure: preventing disease and death worldwide’, just before the Heart Failure 2014 Congress started in Athens.

A project from the World Heart Failure Alliance, the White Paper aims to propose a clear Call to Action by identifying target groups at risk from heart failure and appropriate prevention and treatment which could serve as the basis for future international guidelines. It is to be led by the HFA (with its network of 40 National Heart Failure Societies), with the support of heart failure groups worldwide.

Although heart failure is a preventable disease and outcomes for patients are improving, the complexity of the syndrome represents a major obstacle to adequate identification and diagnosis of untreated patients. This also thwarts understanding of heart failure among politicians and the general public. In addition, heart failure treatment is different in different locations. There is clear evidence that the prevalence of heart failure will rise substantially thus increasing the economic burden on society.

The objectives of the paper begin by positioning heart failure as a serious health threat at European international level and defending early diagnosis, treatment availability and better quality of life for all patients. The Paper will help people to make decisions and raise awareness, plus inform policy makers targeting action for implementation at national level. Furthermore, gaps should be identified in the education of heart failure in different countries and regions of the world.


Bax Credit: Sam Rogers
Professor Jeroen J Bax MD PhD has been appointed Deputy Editor for Imaging at the EHJ on 1 May 2014. He is both Director of non-invasive imaging and Director of the ECHO-lab at the Leiden University Medical Center, The Netherlands.

His main interests include: clinical cardiology, heart failure, cardiac resynchronization therapy and the application of all different imaging modalities to these clinical fields.

Professor Bax has authored numerous papers and holds several positions in national and international scientific organizations. He was President of the ESC Congress program committee for 2007-2008 and the ESC Cardiology Guidelines chair for 2010-2012. He also serves on many editorial boards of different journals, including associate editor for the Journal of American College of Cardiology and Heart.


The SYMPLICITY HTN-3 trial, a phase 3 study testing catheter-based renal denervation for the treatment of resistant hypertension, failed to achieve its primary efficacy end point. The study, which randomized 535 treatment-resistant hypertension patients, failed to show that treatment with the investigational procedure resulted in a sustained reduction in systolic blood pressure.

The results were surprising, given the positive findings from the SYMPLICITY 2. In contrast, the SYMPLICITY HTN-3 study was more rigorously designed to assess the efficacy of the procedure, as all patients randomized to the control arm underwent a sham procedure.

The primary end point of the study was the change in office systolic blood pressure at six months, while the six-month change in the average 24-hour systolic blood pressure assessed by ambulatory blood pressure monitoring was a secondary end point. The primary safety end point was the incidence of major adverse events that occurred one month after treatment until six months. According to Medtronic the catheter manufacturer, no safety issues arose during the trial.

In a statement, Dr George Bakris (University of Chicago, IL), a co-investigator of the study along with Dr Deepak Bhatt (Brigham and Women's Hospital, Boston, MA), said he was disappointed in the result. The news is a blow to the hopes of renal denervation that has seen its share of hype and excitement in recent years. It appears to throw a wrench into the plans of other companies. St Jude Medical halted the EnligHTN-IV study, its large phase 3 study in 590 patients with resistant hypertension. That device used a multi-electrode renal-denervation system in patients with resistant hypertension but was stopped because of concerns about slow enrolment.



Cardiology Update belongs to the major cardiology meetings in Europe. Following a long tradition this will be the 21st Cardiology Update Course which is held every 2nd year in Davos, Switzerland. The course is a joint educational programme by the Foundation of Cardiovascular Research and the European Society of Cardiology. A distinguished international teaching faculty contributes to an outstanding programme on latest developments in clinical research as well as on new intervention and treatment strategies in cardiology.

The aim is to provide high quality continuing education on the latest scientific and therapeutic developments and a forum for an open dialogue with international opinion leaders in cardiology.

Programme directors are Prof. Thomas F. Lüscher, Zurich and Prof. Bertram Pitt, Ann Arbor, MI, USA.

Back to top of page